Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AN2 Therapeutics Logo
AN2 Therapeutics Growth Score
91
CB Rank
6189
Heat Score
68
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Founded
obfuscation
PublicPost-IPO Equity Menlo Park, California, United States11-50 www.an2therapeutics.com
Biotechnology
Health Care
Pharmaceutical
Overview

AN2 Therapeutics
Total Funding
obfuscation
Growth Score
91
Heat Score
68

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score91
-5 pts
in past quarter
Heat Score 68
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AN2 Therapeutics

CB Rank
6189
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Founded
obfuscation
PublicPost-IPO Equity Menlo Park, California, United States11-50 www.an2therapeutics.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Joseph Zakrzewski
    Joseph Zakrzewski: Founder, Investor & Board Member
    Past Role: Amarin, Chairman & CEO
  • Photo of Sanjay Chanda
    Sanjay Chanda: Chief Development Officer
    Past Role: Anacor Pharmaceutical, Senior Vice President of Drug Development

Details

Legal Name AN2 Therapeutics, Inc.
Operating Status Active
Stock Symbol  NASDAQ:ANTX
Company Type For Profit
Founders  Eric Easom, George Talbot, Joseph Zakrzewski, MIchael Alley
About the Company
AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.
Predictions & Insights

Growth Insight

See this Growth Insight
AN2 Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

AN2-502998
An oral boron-based small molecule therapeutic candidate for treating chronic Trypanosoma cruzi infection (Chagas disease).
Epetraborole
An oral boron-containing small molecule inhibitor targeting bacterial leucyl-tRNA synthetase for treating infectious diseases like melioidosis and non-tuberculous mycobacterial lung disease.

Research & Development

AN2 Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
3
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Commodore Capital Logo
Commodore Capital
—
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
—
Commodore Capital Logo
Commodore Capital
—
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
—
Commodore Capital Logo
Commodore Capital
—
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
—
Commodore Capital Logo
Commodore Capital
—
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
—
Commodore Capital Logo
Commodore Capital
—
Post-IPO Equity - AN2 Therapeutics Logo
Post-IPO Equity - AN2 Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Board Members and Advisors 2 Contacts 29

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,932
-30.75%
 in past month

IT Spend

$1.6MThis year, AN2 Therapeutics is projected to spend $1.6M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Research and Development / Test Logo
Research and Development / Test
95
Microsoft (MSFT) Logo
Microsoft (MSFT)
93
Layoff Logo
Layoff
84

Active Website Tech Count

10AN2 Therapeutics is actively using 10 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m, jQuery CDN, and  Mobile Optimized.

Total IP

6The intellectual property of AN2 Therapeutics includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AN2 Therapeutics's headquarters? AN2 Therapeutics is located in Menlo Park, California, United States.Who invested in AN2 Therapeutics? AN2 Therapeutics has 20 investors including Commodore Capital and  Coastlands Capital.When was the last funding round for AN2 Therapeutics? AN2 Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are AN2 Therapeutics's competitors? Alternatives and possible competitors to AN2 Therapeutics may include Avalyn Pharma, PureTech Health, and  Kinvard Bio.How much funding has AN2 Therapeutics raised to date? AN2 Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|